2020
DOI: 10.1016/j.rgmx.2020.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Manifestaciones hepáticas y repercusión en el paciente cirrótico de COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 34 publications
0
8
0
1
Order By: Relevance
“…This could be caused because the perception that any antiretroviral would have a positive effect against the viral COVID-19 infection. However, liver damage has been observed in COVID-19 patients ( Velarde-Ruiz Velasco et al, 2020 ). Considering that antiretrovirals list liver damage as a common adverse effect ( Alonso-Bello et al, 2018 , Mallolas et al, 2003 ), it would make them inappropriate for use in COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%
“…This could be caused because the perception that any antiretroviral would have a positive effect against the viral COVID-19 infection. However, liver damage has been observed in COVID-19 patients ( Velarde-Ruiz Velasco et al, 2020 ). Considering that antiretrovirals list liver damage as a common adverse effect ( Alonso-Bello et al, 2018 , Mallolas et al, 2003 ), it would make them inappropriate for use in COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that smoking may increase multiple enzymes in the human liver. Cirrhosis of the liver has a recognized immune dysfunction status that includes immunodeficiency and systemic inflammation, making it reasonable for those patients to be more susceptible to SARS-CoV-2 infection ( Velarde-Ruiz Velasco et al, 2020 ). In this study, the data we collected containing a total of 1,547 patients with 150 smokers, which will provide a better understanding of the effects of CS in COVID-19.…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the consumption of antiretrovirals in order to prevent a viral disease such as COVID-19 it is risky because liver damage has been observed in COVID-19 patients. 127 Considering that antiretrovirals list liver damage as a common adverse effect, 128 , 129 it would make them inappropriate for use in COVID-19 patients. Their use is relevant for other pathologies, but a recent review has determined that there is no clear evidence of the beneficial effects of antiretrovirals in the prevention of COVID-19.…”
Section: Prescription Drugsmentioning
confidence: 99%